戻る Agenda
Session 8: Where are we Heading? The US and EU Industry associations’ perspective
Session Chair(s)
Merete Joergensen, MBA, MSC
Clinical Disclosure and Transparency Expert
Merete-J Consulting, Denmark
Where are we Heading? The US and EU Industry associations’ perspective
Speaker(s)
Olivia Shopshear, MS
Biogen, United States
Senior Director, US Regulatory Policy Lead
Sini Eskola, MPHARM, MS, MSC
Takeda, Belgium
Head of International Regulatory Policy and Innovation